SCHEMBL25815443

SCHEMBL25815443

CCCCCCOC1COc2cc(C(C)(C)C)ccc2OCC(OC)COc2ccc(C(C)(C)C)cc2OC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.36
THRA P10827 1/20 0.34
THRB P10828 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
GHSR Q92847 1/20 0.33
NR1I2 O75469 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
FFAR1 O14842 2/20 0.32
PPARG P37231 2/20 0.32
PPARD Q03181 2/20 0.32
MAPT P10636 2/20 0.32
LMNA P02545 1/20 0.32
HSP90AA1 P07900 1/20 0.32
HTT P42858 1/20 0.32
RECQL P46063 1/20 0.32
ALDH1A1 P00352 2/20 0.32
AIMP2 Q13155 1/20 0.32
RAB9A P51151 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22134649 0.88 CYP19A1 (0.33) CYP19A1THRATHRBMEN1KMT2A
SCHEMBL22134728 0.87 FFAR1 (0.39) CYP19A1MEN1KMT2ANR1I2FFAR1
SCHEMBL22134647 0.86 CYP19A1 (0.34) CYP19A1THRATHRBMEN1KMT2A
SCHEMBL22134725 0.80 FFAR1 (0.38) CYP19A1MEN1KMT2AFFAR1PPARG
SCHEMBL22134636 0.73 CYP19A1 (0.44) CYP19A1FFAR1PPARGPPARDMAPT
SCHEMBL10025618 0.71 GBA1 (0.39) THRATHRBMEN1KMT2ALMNA
SCHEMBL23024716 0.68 CYP19A1 (0.46) CYP19A1MAPTLMNAHSP90AA1HTT
SCHEMBL22134638 0.68 ALDH1A1 (0.41) CYP19A1MEN1KMT2AFFAR1PPARG
SCHEMBL22134628 0.67 CYP19A1 (0.44) CYP19A1MEN1KMT2AMAPTLMNA
SCHEMBL22134659 0.67 CYP19A1 (0.43) CYP19A1MEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219919-A1 LITHIUM EXTRACTION WITH CROWN ETHERS ORCA HOLDINGS, LLC 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219919-A1 LITHIUM EXTRACTION WITH CROWN ETHERS LCLAT1, LCT, IGF2R CYP19A1 4811/4885THRA 1652/4885THRB 1674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.